InvestSMART

Prescient Therapeutics Limited (ASX: PTX) - Announcements

Current share price for PTX : $0.054 0.001 (1.89%)+

ASX company news and announcements for Prescient Therapeutics Limited (PTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Prescient Therapeutics Limited (PTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Prescient Therapeutics Limited (PTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Prescient Therapeutics Limited (PTX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$62 Change of Company Secretary 23 Oct 2026 9:45AM $0.056 $0.054 fallen by 3.57%
$62 Results of Annual General Meeting 14 Oct 2026 4:05PM $0.065 $0.054 fallen by 16.92%
$62 Chair Address and CEO AGM Presentation 14 Oct 2026 10:47AM $0.065 $0.054 fallen by 16.92%
$62 September 2026 Quarterly Update and Appendix 4C 13 Oct 2026 9:39AM $0.064 $0.054 fallen by 15.63%
$62 Change of Director's Interest Notice 6 Oct 2026 11:05AM $0.064 $0.054 fallen by 15.63%
$62 Change of Director's Interest Notice 6 Oct 2026 11:04AM $0.064 $0.054 fallen by 15.63%
$62 Change of Director's Interest Notice 6 Oct 2026 11:03AM $0.064 $0.054 fallen by 15.63%
$62 Notification regarding unquoted securities - PTX 30 Sep 2026 11:07AM $0.069 $0.054 fallen by 21.74%
$62 Section 708A Cleansing Notice 30 Sep 2026 9:49AM $0.072 $0.054 fallen by 25%
$62 Application for quotation of securities - PTX 30 Sep 2026 9:45AM $0.072 $0.054 fallen by 25%
$62 Application for quotation of securities - PTX 30 Sep 2026 9:44AM $0.072 $0.054 fallen by 25%
$62 Proposed issue of securities - PTX 23 Sep 2026 10:04AM $0.068 $0.054 fallen by 20.59%
$62 PTX Successfully Completes $6m Raise Via SPP and Placement 23 Sep 2026 10:03AM $0.068 $0.054 fallen by 20.59%
$62 Trading Halt 21 Sep 2026 9:33AM $0.068 $0.054 fallen by 20.59%
$62 Update - Proposed issue of securities - PTX 15 Sep 2026 11:54AM $0.068 $0.054 fallen by 20%
$62 Prescient Therapeutics - Extension of Share Purchase Plan 15 Sep 2026 9:00AM $0.065 $0.054 fallen by 16.92%
$62 Notice of Annual General Meeting/Proxy Form 14 Sep 2026 9:10AM $0.068 $0.054 fallen by 20.59%
$62 Update - Proposed issue of securities - PTX 8 Sep 2026 9:18AM $0.068 $0.054 fallen by 20.59%
$62 Prescient Therapeutics - Extension of Share Purchase Plan 8 Sep 2026 9:03AM $0.068 $0.054 fallen by 20.59%
$62 PTX-100 CTCL Phase 2a study reaches review milestone 2 Sep 2026 2:10PM $0.067 $0.054 fallen by 19.40%
$62 Prescient Share Purchase Plan Investor Presentation 26 Aug 2026 9:53AM $0.067 $0.054 fallen by 19.40%
$62 Prescient Therapeutics Opens SPP to Raise $7m Today 26 Aug 2026 8:57AM $0.067 $0.054 fallen by 19.40%
$62 Share Purchase Plan Cleansing Notice 26 Aug 2026 8:45AM $0.067 $0.054 fallen by 19.40%
$62 Proposed issue of securities - PTX 25 Aug 2026 2:47PM $0.066 $0.054 fallen by 18.18%
$62 Prescient Therapeutics Launches Share Purchase Plan for $7m 25 Aug 2026 9:06AM $0.072 $0.054 fallen by 25%

1 - 25 of 597 results

Page 1 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.